

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.51558870 |
| 2 | negative regulation of cell killing (GO:0031342) | 6.97982377 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.97982377 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.38564110 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.38564110 |
| 6 | negative T cell selection (GO:0043383) | 6.36789473 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.16069633 |
| 8 | negative thymic T cell selection (GO:0045060) | 5.96708266 |
| 9 | leukocyte aggregation (GO:0070486) | 5.91737128 |
| 10 | interferon-gamma production (GO:0032609) | 5.90929843 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.88733765 |
| 12 | positive thymic T cell selection (GO:0045059) | 5.81986873 |
| 13 | positive regulation by symbiont of host defense response (GO:0052509) | 5.72267946 |
| 14 | modulation by symbiont of host defense response (GO:0052031) | 5.72267946 |
| 15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.72267946 |
| 16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.72267946 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.72267946 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 5.72267946 |
| 19 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.57006777 |
| 20 | T cell migration (GO:0072678) | 5.50760435 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.50143945 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 5.44465278 |
| 23 | positive T cell selection (GO:0043368) | 5.41390278 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.13790214 |
| 25 | thymic T cell selection (GO:0045061) | 4.93371529 |
| 26 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.90884083 |
| 27 | response to interleukin-15 (GO:0070672) | 4.89877815 |
| 28 | cellular response to interleukin-15 (GO:0071350) | 4.79667111 |
| 29 | detection of molecule of bacterial origin (GO:0032490) | 4.71004247 |
| 30 | T cell selection (GO:0045058) | 4.70981312 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 4.70374321 |
| 32 | detection of bacterium (GO:0016045) | 4.60140789 |
| 33 | response to peptidoglycan (GO:0032494) | 4.56983117 |
| 34 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.46880429 |
| 35 | detection of external biotic stimulus (GO:0098581) | 4.45481439 |
| 36 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.32118134 |
| 37 | negative regulation of interleukin-12 production (GO:0032695) | 4.23521205 |
| 38 | microglial cell activation (GO:0001774) | 4.21714732 |
| 39 | T cell receptor signaling pathway (GO:0050852) | 4.20996635 |
| 40 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.18336555 |
| 41 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.11799633 |
| 42 | response to host immune response (GO:0052572) | 4.04265940 |
| 43 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.04265940 |
| 44 | activated T cell proliferation (GO:0050798) | 4.03154057 |
| 45 | regulation of B cell differentiation (GO:0045577) | 4.02471303 |
| 46 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.00073206 |
| 47 | respiratory burst (GO:0045730) | 3.99510620 |
| 48 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.96447532 |
| 49 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.96403262 |
| 50 | T cell costimulation (GO:0031295) | 3.96390195 |
| 51 | detection of biotic stimulus (GO:0009595) | 3.95702660 |
| 52 | mast cell activation (GO:0045576) | 3.95162818 |
| 53 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.93653270 |
| 54 | lymphocyte costimulation (GO:0031294) | 3.91429320 |
| 55 | granulocyte activation (GO:0036230) | 3.90121657 |
| 56 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.87980090 |
| 57 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.86913280 |
| 58 | immunoglobulin mediated immune response (GO:0016064) | 3.86602518 |
| 59 | B cell receptor signaling pathway (GO:0050853) | 3.84244433 |
| 60 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.84235923 |
| 61 | neutrophil mediated immunity (GO:0002446) | 3.83422795 |
| 62 | negative regulation of T cell mediated immunity (GO:0002710) | 3.81489343 |
| 63 | leukocyte cell-cell adhesion (GO:0007159) | 3.81409915 |
| 64 | myeloid cell activation involved in immune response (GO:0002275) | 3.75636626 |
| 65 | macrophage activation (GO:0042116) | 3.75136630 |
| 66 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.74539517 |
| 67 | cellular extravasation (GO:0045123) | 3.73832629 |
| 68 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.71235346 |
| 69 | response to host (GO:0075136) | 3.71235346 |
| 70 | response to host defenses (GO:0052200) | 3.71235346 |
| 71 | positive regulation of isotype switching (GO:0045830) | 3.70428078 |
| 72 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.63485190 |
| 73 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.62703451 |
| 74 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.61780777 |
| 75 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.61780777 |
| 76 | regulation of mast cell degranulation (GO:0043304) | 3.59533059 |
| 77 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.58834199 |
| 78 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.52371799 |
| 79 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.49080745 |
| 80 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.49080745 |
| 81 | regulation of T cell tolerance induction (GO:0002664) | 3.46814187 |
| 82 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.44378432 |
| 83 | positive regulation of B cell mediated immunity (GO:0002714) | 3.44378432 |
| 84 | positive regulation of mast cell activation (GO:0033005) | 3.40765364 |
| 85 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.40239715 |
| 86 | regulation of regulatory T cell differentiation (GO:0045589) | 3.40189495 |
| 87 | regulation of tolerance induction (GO:0002643) | 3.35877681 |
| 88 | positive regulation of B cell differentiation (GO:0045579) | 3.35173241 |
| 89 | positive regulation of DNA recombination (GO:0045911) | 3.33490813 |
| 90 | leukocyte degranulation (GO:0043299) | 3.33470774 |
| 91 | response to muramyl dipeptide (GO:0032495) | 3.32138944 |
| 92 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.31320653 |
| 93 | positive regulation of humoral immune response (GO:0002922) | 3.30986793 |
| 94 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.30358355 |
| 95 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.29916552 |
| 96 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.29309359 |
| 97 | myeloid leukocyte mediated immunity (GO:0002444) | 3.28147444 |
| 98 | regulation of response to interferon-gamma (GO:0060330) | 3.27679174 |
| 99 | regulation of mast cell activation (GO:0033003) | 3.27341698 |
| 100 | T cell homeostasis (GO:0043029) | 3.25799846 |
| 101 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.23271221 |
| 102 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.21704597 |
| 103 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.20364822 |
| 104 | natural killer cell activation (GO:0030101) | 3.16323188 |
| 105 | response to type I interferon (GO:0034340) | 3.16201831 |
| 106 | dendritic cell migration (GO:0036336) | 3.15459433 |
| 107 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.15029269 |
| 108 | heterotypic cell-cell adhesion (GO:0034113) | 3.14941196 |
| 109 | regulation of B cell mediated immunity (GO:0002712) | 3.14720620 |
| 110 | regulation of isotype switching (GO:0045191) | 3.14690448 |
| 111 | B cell mediated immunity (GO:0019724) | 3.13891670 |
| 112 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.13834622 |
| 113 | regulation of leukocyte degranulation (GO:0043300) | 3.13008729 |
| 114 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.12385940 |
| 115 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.12385940 |
| 116 | positive regulation of interleukin-2 production (GO:0032743) | 3.11176771 |
| 117 | cellular defense response (GO:0006968) | 3.10054490 |
| 118 | type I interferon signaling pathway (GO:0060337) | 3.09446895 |
| 119 | cellular response to type I interferon (GO:0071357) | 3.09446895 |
| 120 | T cell differentiation (GO:0030217) | 3.07954733 |
| 121 | lymphocyte migration (GO:0072676) | 3.07842931 |
| 122 | regulation of cell killing (GO:0031341) | 3.07461589 |
| 123 | dendritic cell chemotaxis (GO:0002407) | 3.06872447 |
| 124 | ribosomal small subunit assembly (GO:0000028) | 3.06784804 |
| 125 | defense response to protozoan (GO:0042832) | 3.05389252 |
| 126 | positive regulation of tolerance induction (GO:0002645) | 3.04939498 |
| 127 | positive regulation of lamellipodium assembly (GO:0010592) | 3.04338024 |
| 128 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.03186548 |
| 129 | T cell proliferation (GO:0042098) | 3.01786386 |
| 130 | germinal center formation (GO:0002467) | 3.00376445 |
| 131 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.99912211 |
| 132 | tolerance induction (GO:0002507) | 2.99548988 |
| 133 | positive regulation of cell killing (GO:0031343) | 2.99258802 |
| 134 | sequestering of actin monomers (GO:0042989) | 2.98748028 |
| 135 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.98287205 |
| 136 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.97818772 |
| 137 | neutrophil activation (GO:0042119) | 2.97327843 |
| 138 | T cell activation (GO:0042110) | 2.96984906 |
| 139 | alpha-beta T cell activation (GO:0046631) | 2.96355293 |
| 140 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.95240566 |
| 141 | myeloid dendritic cell activation (GO:0001773) | 2.95145495 |
| 142 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.93938890 |
| 143 | negative regulation of interleukin-6 production (GO:0032715) | 2.93764558 |
| 144 | negative regulation of phagocytosis (GO:0050765) | 2.93698639 |
| 145 | megakaryocyte development (GO:0035855) | 2.93532911 |
| 146 | lymphocyte homeostasis (GO:0002260) | 2.92245530 |
| 147 | negative regulation of innate immune response (GO:0045824) | 2.92166629 |
| 148 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.92155491 |
| 149 | detection of other organism (GO:0098543) | 2.90848270 |
| 150 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.88752574 |
| 151 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.87248254 |
| 152 | neutrophil activation involved in immune response (GO:0002283) | 2.86360915 |
| 153 | mast cell activation involved in immune response (GO:0002279) | 2.86203677 |
| 154 | mast cell degranulation (GO:0043303) | 2.86203677 |
| 155 | positive regulation of granulocyte differentiation (GO:0030854) | 2.84543422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.44222767 |
| 2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.64028038 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.83621855 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.13529539 |
| 5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.76109578 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.44731900 |
| 7 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.40132343 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.36896723 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.33737779 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.32562000 |
| 11 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.15564456 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 3.04855867 |
| 13 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.01178991 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.89980145 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.83866358 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.72393956 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.71323525 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.67566638 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.66284163 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.65761004 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.53911524 |
| 22 | MYB_26560356_Chip-Seq_TH1_Human | 2.52985290 |
| 23 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.51180126 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.43920689 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.42455469 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 2.37101290 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.19053029 |
| 28 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.17297784 |
| 29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.12904673 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.12668537 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10363360 |
| 32 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.08912988 |
| 33 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.05011192 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.01466955 |
| 35 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.97950804 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97264049 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.85805023 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.85089311 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.78969117 |
| 40 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.76109842 |
| 41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.73578421 |
| 42 | MAF_26560356_Chip-Seq_TH2_Human | 1.71892637 |
| 43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67697454 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66433212 |
| 45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66130662 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.64484880 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61931694 |
| 48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.58995492 |
| 49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54429627 |
| 50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53918861 |
| 51 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.48834885 |
| 52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48797792 |
| 53 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.38904458 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.38637641 |
| 55 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.35666895 |
| 56 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.35302936 |
| 57 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33424517 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32447481 |
| 59 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30101254 |
| 60 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.29695464 |
| 61 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.29046374 |
| 62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.27969998 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25807540 |
| 64 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25390057 |
| 65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.22733325 |
| 66 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20768533 |
| 67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.19858789 |
| 68 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.18574044 |
| 69 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.18461328 |
| 70 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14935935 |
| 71 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14749971 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12906392 |
| 73 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11436727 |
| 74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07394537 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07034763 |
| 76 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06758408 |
| 77 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05913525 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04640889 |
| 79 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03874107 |
| 80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03464232 |
| 81 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.02462099 |
| 82 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.00159116 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00075002 |
| 84 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.99743356 |
| 85 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97947349 |
| 86 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97248361 |
| 87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97095236 |
| 88 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.95226846 |
| 89 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94777303 |
| 90 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92513624 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.91541525 |
| 92 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90776971 |
| 93 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89589147 |
| 94 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.89369209 |
| 95 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89278219 |
| 96 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88197372 |
| 97 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.86609551 |
| 98 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.86478084 |
| 99 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83526886 |
| 100 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80717157 |
| 101 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80017408 |
| 102 | GATA2_19941826_ChIP-Seq_K562_Human | 0.77906613 |
| 103 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.77516468 |
| 104 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77377090 |
| 105 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.77144144 |
| 106 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.76611571 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75267000 |
| 108 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74841216 |
| 109 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74753874 |
| 110 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.74602633 |
| 111 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.74102568 |
| 112 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.73632627 |
| 113 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.72842563 |
| 114 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.69568505 |
| 115 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.68528246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.32885424 |
| 2 | MP0005671_abnormal_response_to | 3.98004424 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.59872692 |
| 4 | MP0000685_abnormal_immune_system | 3.41576307 |
| 5 | MP0009785_altered_susceptibility_to | 3.35863808 |
| 6 | MP0001800_abnormal_humoral_immune | 3.08433578 |
| 7 | MP0003436_decreased_susceptibility_to | 2.96256725 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.93360754 |
| 9 | MP0002420_abnormal_adaptive_immunity | 2.90647849 |
| 10 | MP0001819_abnormal_immune_cell | 2.86681294 |
| 11 | MP0005387_immune_system_phenotype | 2.81826230 |
| 12 | MP0001790_abnormal_immune_system | 2.81826230 |
| 13 | MP0002723_abnormal_immune_serum | 2.79645856 |
| 14 | MP0005025_abnormal_response_to | 2.78133444 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.71828522 |
| 16 | MP0003724_increased_susceptibility_to | 2.71616579 |
| 17 | MP0002166_altered_tumor_susceptibility | 2.71026330 |
| 18 | MP0002398_abnormal_bone_marrow | 2.67071892 |
| 19 | MP0002419_abnormal_innate_immunity | 2.46583345 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.45963179 |
| 21 | MP0000716_abnormal_immune_system | 2.40186522 |
| 22 | MP0006082_CNS_inflammation | 2.39547675 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 2.39288539 |
| 24 | MP0002405_respiratory_system_inflammati | 2.37178576 |
| 25 | MP0002396_abnormal_hematopoietic_system | 2.32418565 |
| 26 | MP0002006_tumorigenesis | 2.23220571 |
| 27 | MP0005464_abnormal_platelet_physiology | 2.21155695 |
| 28 | MP0001873_stomach_inflammation | 2.19274452 |
| 29 | MP0000689_abnormal_spleen_morphology | 2.18918709 |
| 30 | MP0002722_abnormal_immune_system | 2.18208286 |
| 31 | MP0000703_abnormal_thymus_morphology | 2.11846274 |
| 32 | MP0010155_abnormal_intestine_physiology | 2.07692668 |
| 33 | MP0002429_abnormal_blood_cell | 1.98590643 |
| 34 | MP0003303_peritoneal_inflammation | 1.89407074 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.86545972 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.85450902 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.84933532 |
| 38 | MP0008260_abnormal_autophagy | 1.84616822 |
| 39 | MP0004947_skin_inflammation | 1.83718823 |
| 40 | MP0003300_gastrointestinal_ulcer | 1.82426984 |
| 41 | MP0003866_abnormal_defecation | 1.73680011 |
| 42 | MP0000858_altered_metastatic_potential | 1.70813782 |
| 43 | MP0001853_heart_inflammation | 1.70048737 |
| 44 | MP0002933_joint_inflammation | 1.68911879 |
| 45 | MP0009278_abnormal_bone_marrow | 1.68304314 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.58115056 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.58115056 |
| 48 | MP0003448_altered_tumor_morphology | 1.42956368 |
| 49 | MP0004510_myositis | 1.39380502 |
| 50 | MP0002009_preneoplasia | 1.37469004 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.36621976 |
| 52 | MP0002132_abnormal_respiratory_system | 1.36363343 |
| 53 | MP0004883_abnormal_blood_vessel | 1.36218798 |
| 54 | MP0008469_abnormal_protein_level | 1.34549898 |
| 55 | MP0005451_abnormal_body_composition | 1.34437608 |
| 56 | MP0004381_abnormal_hair_follicle | 1.31954074 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.27103112 |
| 58 | MP0000490_abnormal_crypts_of | 1.21936088 |
| 59 | MP0009764_decreased_sensitivity_to | 1.19861583 |
| 60 | MP0005174_abnormal_tail_pigmentation | 1.18952738 |
| 61 | MP0006054_spinal_hemorrhage | 1.16098446 |
| 62 | MP0001851_eye_inflammation | 1.10969582 |
| 63 | MP0005164_abnormal_response_to | 1.10946335 |
| 64 | MP0008004_abnormal_stomach_pH | 1.07302612 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 1.03891108 |
| 66 | MP0002019_abnormal_tumor_incidence | 1.02816097 |
| 67 | MP0003828_pulmonary_edema | 0.99472387 |
| 68 | MP0000343_altered_response_to | 0.97620434 |
| 69 | MP0003690_abnormal_glial_cell | 0.97484050 |
| 70 | MP0000569_abnormal_digit_pigmentation | 0.93693232 |
| 71 | MP0003045_fibrosis | 0.92753359 |
| 72 | MP0002998_abnormal_bone_remodeling | 0.90598805 |
| 73 | MP0005310_abnormal_salivary_gland | 0.90216614 |
| 74 | MP0004130_abnormal_muscle_cell | 0.87243954 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 0.87234280 |
| 76 | MP0005058_abnormal_lysosome_morphology | 0.86621183 |
| 77 | MP0009763_increased_sensitivity_to | 0.84028177 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 0.81686487 |
| 79 | MP0005023_abnormal_wound_healing | 0.78483041 |
| 80 | MP0005166_decreased_susceptibility_to | 0.76052455 |
| 81 | MP0003183_abnormal_peptide_metabolism | 0.75061247 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.73686544 |
| 83 | MP0004484_altered_response_of | 0.73007561 |
| 84 | MP0000604_amyloidosis | 0.70230574 |
| 85 | MP0003279_aneurysm | 0.68942150 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.68587043 |
| 87 | MP0003795_abnormal_bone_structure | 0.65726170 |
| 88 | MP0001986_abnormal_taste_sensitivity | 0.64929508 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 0.64233507 |
| 90 | MP0002095_abnormal_skin_pigmentation | 0.63945619 |
| 91 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62279924 |
| 92 | MP0003566_abnormal_cell_adhesion | 0.60957248 |
| 93 | MP0008874_decreased_physiological_sensi | 0.60806415 |
| 94 | MP0002332_abnormal_exercise_endurance | 0.59904509 |
| 95 | MP0003172_abnormal_lysosome_physiology | 0.58924980 |
| 96 | MP0000249_abnormal_blood_vessel | 0.58516970 |
| 97 | MP0010352_gastrointestinal_tract_polyps | 0.53606206 |
| 98 | MP0001191_abnormal_skin_condition | 0.53345899 |
| 99 | MP0001663_abnormal_digestive_system | 0.52521423 |
| 100 | MP0005390_skeleton_phenotype | 0.52430370 |
| 101 | MP0002136_abnormal_kidney_physiology | 0.52402278 |
| 102 | MP0000015_abnormal_ear_pigmentation | 0.51444949 |
| 103 | MP0002133_abnormal_respiratory_system | 0.51430651 |
| 104 | MP0005388_respiratory_system_phenotype | 0.51430651 |
| 105 | MP0003252_abnormal_bile_duct | 0.51305636 |
| 106 | MP0003943_abnormal_hepatobiliary_system | 0.50505093 |
| 107 | MP0002693_abnormal_pancreas_physiology | 0.49731440 |
| 108 | MP0000609_abnormal_liver_physiology | 0.48400635 |
| 109 | MP0002277_abnormal_respiratory_mucosa | 0.47773650 |
| 110 | MP0002928_abnormal_bile_duct | 0.47433064 |
| 111 | MP0005319_abnormal_enzyme/_coenzyme | 0.47350731 |
| 112 | MP0008057_abnormal_DNA_replication | 0.45860939 |
| 113 | MP0003075_altered_response_to | 0.45554504 |
| 114 | MP0000477_abnormal_intestine_morphology | 0.44934603 |
| 115 | MP0001243_abnormal_dermal_layer | 0.42494373 |
| 116 | MP0008058_abnormal_DNA_repair | 0.42410077 |
| 117 | MP0001216_abnormal_epidermal_layer | 0.42129642 |
| 118 | MP0008873_increased_physiological_sensi | 0.39799998 |
| 119 | MP0003077_abnormal_cell_cycle | 0.39722682 |
| 120 | MP0000313_abnormal_cell_death | 0.37687641 |
| 121 | MP0000598_abnormal_liver_morphology | 0.35401218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.03959628 |
| 2 | Abnormality of T cell number (HP:0011839) | 5.78572943 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.23693625 |
| 4 | Eczematoid dermatitis (HP:0000976) | 5.10908870 |
| 5 | Myositis (HP:0100614) | 5.04669924 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.59743749 |
| 7 | Abnormality of T cells (HP:0002843) | 4.49806416 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.36507083 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 4.36164805 |
| 10 | Stomatitis (HP:0010280) | 4.30533821 |
| 11 | Chronic otitis media (HP:0000389) | 4.22102341 |
| 12 | IgM deficiency (HP:0002850) | 4.07879039 |
| 13 | Recurrent bronchitis (HP:0002837) | 4.07337696 |
| 14 | Recurrent viral infections (HP:0004429) | 4.04044123 |
| 15 | Pustule (HP:0200039) | 3.98575934 |
| 16 | Severe combined immunodeficiency (HP:0004430) | 3.83128095 |
| 17 | Combined immunodeficiency (HP:0005387) | 3.79089971 |
| 18 | Spontaneous hematomas (HP:0007420) | 3.73962482 |
| 19 | Nasal polyposis (HP:0100582) | 3.72578515 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.64429953 |
| 21 | Optic neuritis (HP:0100653) | 3.64429953 |
| 22 | Meningitis (HP:0001287) | 3.62495450 |
| 23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.60053564 |
| 24 | Orchitis (HP:0100796) | 3.55357163 |
| 25 | Abnormality of the nasal mucosa (HP:0000433) | 3.50584340 |
| 26 | Panhypogammaglobulinemia (HP:0003139) | 3.50024737 |
| 27 | IgG deficiency (HP:0004315) | 3.45995886 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.44904777 |
| 29 | Obstructive lung disease (HP:0006536) | 3.42003810 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.42003810 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 3.39876265 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.39876265 |
| 33 | Encephalitis (HP:0002383) | 3.38416978 |
| 34 | Thrombocytosis (HP:0001894) | 3.35129837 |
| 35 | Recurrent skin infections (HP:0001581) | 3.32272081 |
| 36 | Hypochromic microcytic anemia (HP:0004840) | 3.25592331 |
| 37 | Inflammation of the large intestine (HP:0002037) | 3.24585661 |
| 38 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.22851138 |
| 39 | Abnormality of eosinophils (HP:0001879) | 3.18172587 |
| 40 | Thyroiditis (HP:0100646) | 3.16720874 |
| 41 | Leukocytosis (HP:0001974) | 3.15447199 |
| 42 | Lymphopenia (HP:0001888) | 3.11835999 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 3.11308657 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 3.07828262 |
| 45 | Prolonged bleeding time (HP:0003010) | 3.05445777 |
| 46 | Autoimmune thrombocytopenia (HP:0001973) | 3.04817333 |
| 47 | Autoimmune hemolytic anemia (HP:0001890) | 3.04662702 |
| 48 | Episodic fever (HP:0001954) | 3.02762452 |
| 49 | Eosinophilia (HP:0001880) | 2.99990925 |
| 50 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.97928503 |
| 51 | Abnormality of macrophages (HP:0004311) | 2.92996268 |
| 52 | Vasculitis (HP:0002633) | 2.92719163 |
| 53 | Chronic diarrhea (HP:0002028) | 2.92577890 |
| 54 | Hypochromic anemia (HP:0001931) | 2.91649895 |
| 55 | Increased IgM level (HP:0003496) | 2.90247109 |
| 56 | Epistaxis (HP:0000421) | 2.89434984 |
| 57 | Peritonitis (HP:0002586) | 2.89038726 |
| 58 | Anorexia (HP:0002039) | 2.88428102 |
| 59 | Keratoconjunctivitis sicca (HP:0001097) | 2.83726655 |
| 60 | Hemoptysis (HP:0002105) | 2.81574048 |
| 61 | Abnormality of the fingertips (HP:0001211) | 2.81323040 |
| 62 | Agammaglobulinemia (HP:0004432) | 2.78581202 |
| 63 | Arterial thrombosis (HP:0004420) | 2.73363052 |
| 64 | Amyloidosis (HP:0011034) | 2.71549670 |
| 65 | Granulocytopenia (HP:0001913) | 2.71029744 |
| 66 | Petechiae (HP:0000967) | 2.68835887 |
| 67 | Pulmonary infiltrates (HP:0002113) | 2.67283747 |
| 68 | Gangrene (HP:0100758) | 2.67037584 |
| 69 | Cellulitis (HP:0100658) | 2.63106262 |
| 70 | Abnormal platelet volume (HP:0011876) | 2.56263381 |
| 71 | Keratoconjunctivitis (HP:0001096) | 2.54717760 |
| 72 | Recurrent sinusitis (HP:0011108) | 2.53089094 |
| 73 | Joint swelling (HP:0001386) | 2.51932122 |
| 74 | Verrucae (HP:0200043) | 2.51273582 |
| 75 | Papilloma (HP:0012740) | 2.51273582 |
| 76 | Abnormality of B cell number (HP:0010975) | 2.48948732 |
| 77 | B lymphocytopenia (HP:0010976) | 2.48948732 |
| 78 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.46826604 |
| 79 | Increased IgE level (HP:0003212) | 2.45806064 |
| 80 | Pulmonary embolism (HP:0002204) | 2.45770821 |
| 81 | Gingivitis (HP:0000230) | 2.45721834 |
| 82 | Gingival bleeding (HP:0000225) | 2.45631736 |
| 83 | Hypergammaglobulinemia (HP:0010702) | 2.44404487 |
| 84 | Abnormality of the pleura (HP:0002103) | 2.43568213 |
| 85 | Colitis (HP:0002583) | 2.41107729 |
| 86 | Bronchitis (HP:0012387) | 2.40861368 |
| 87 | Osteomyelitis (HP:0002754) | 2.39089177 |
| 88 | Chest pain (HP:0100749) | 2.37358993 |
| 89 | IgA deficiency (HP:0002720) | 2.34737317 |
| 90 | Gastrointestinal infarctions (HP:0005244) | 2.30763590 |
| 91 | Acute hepatic failure (HP:0006554) | 2.29496363 |
| 92 | Glomerulopathy (HP:0100820) | 2.29495160 |
| 93 | Vertigo (HP:0002321) | 2.25689626 |
| 94 | Abnormality of the peritoneum (HP:0002585) | 2.25367586 |
| 95 | Chronic sinusitis (HP:0011109) | 2.24076829 |
| 96 | Abnormality of the endocardium (HP:0004306) | 2.23927562 |
| 97 | Lymphoma (HP:0002665) | 2.22101866 |
| 98 | Fatigue (HP:0012378) | 2.17265656 |
| 99 | Interstitial pulmonary disease (HP:0006530) | 2.16932040 |
| 100 | Hypoplasia of the thymus (HP:0000778) | 2.14839891 |
| 101 | Abnormality of the prostate (HP:0008775) | 2.12309922 |
| 102 | Vacuolated lymphocytes (HP:0001922) | 2.09100788 |
| 103 | Viral hepatitis (HP:0006562) | 2.06040353 |
| 104 | Periodontitis (HP:0000704) | 2.05357671 |
| 105 | Keratitis (HP:0000491) | 2.05179618 |
| 106 | Microcytic anemia (HP:0001935) | 2.01665552 |
| 107 | Skin ulcer (HP:0200042) | 2.01503090 |
| 108 | Purpura (HP:0000979) | 1.99545258 |
| 109 | Polyneuropathy (HP:0001271) | 1.98820413 |
| 110 | Increased mean platelet volume (HP:0011877) | 1.98101916 |
| 111 | Slow saccadic eye movements (HP:0000514) | 1.97245958 |
| 112 | Acne (HP:0001061) | 1.96877413 |
| 113 | Amaurosis fugax (HP:0100576) | 1.94241309 |
| 114 | Thrombophlebitis (HP:0004418) | 1.93341552 |
| 115 | Subacute progressive viral hepatitis (HP:0006572) | 1.92986048 |
| 116 | Abnormality of the pericardium (HP:0001697) | 1.89414778 |
| 117 | Skin rash (HP:0000988) | 1.87874255 |
| 118 | Aplastic anemia (HP:0001915) | 1.87471560 |
| 119 | Urticaria (HP:0001025) | 1.86626950 |
| 120 | Basal cell carcinoma (HP:0002671) | 1.86504307 |
| 121 | Hematochezia (HP:0002573) | 1.85124887 |
| 122 | Hepatosplenomegaly (HP:0001433) | 1.85046143 |
| 123 | Increased serum ferritin (HP:0003281) | 1.84927732 |
| 124 | Poikiloderma (HP:0001029) | 1.84087136 |
| 125 | Papilledema (HP:0001085) | 1.83292357 |
| 126 | Sepsis (HP:0100806) | 1.81372688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 5.46828827 |
| 2 | MAP4K1 | 5.07905196 |
| 3 | ITK | 3.06102029 |
| 4 | IRAK4 | 2.97793648 |
| 5 | ZAP70 | 2.90018758 |
| 6 | STK10 | 2.80283839 |
| 7 | JAK3 | 2.79482684 |
| 8 | TEC | 2.56519663 |
| 9 | BTK | 2.40918972 |
| 10 | TYK2 | 2.31818316 |
| 11 | IKBKE | 2.30018872 |
| 12 | CSK | 2.13655974 |
| 13 | NLK | 2.02074810 |
| 14 | GRK6 | 2.01782242 |
| 15 | PRPF4B | 1.92087319 |
| 16 | BLK | 1.90966288 |
| 17 | FGFR4 | 1.89527965 |
| 18 | JAK1 | 1.88539874 |
| 19 | MAP3K14 | 1.75867628 |
| 20 | TGFBR2 | 1.75758093 |
| 21 | LCK | 1.71426988 |
| 22 | SYK | 1.65526428 |
| 23 | TBK1 | 1.64832602 |
| 24 | FGR | 1.61038114 |
| 25 | KIT | 1.53893137 |
| 26 | HCK | 1.51846520 |
| 27 | CLK1 | 1.50264817 |
| 28 | TAOK1 | 1.41492895 |
| 29 | LRRK2 | 1.37109201 |
| 30 | FES | 1.31982760 |
| 31 | MAP3K11 | 1.30077722 |
| 32 | FGFR3 | 1.29686705 |
| 33 | KSR2 | 1.28906057 |
| 34 | FLT3 | 1.28478090 |
| 35 | MAP2K3 | 1.24783823 |
| 36 | YES1 | 1.22995524 |
| 37 | BMPR2 | 1.21815111 |
| 38 | MAP3K13 | 1.21128988 |
| 39 | IKBKB | 1.19523436 |
| 40 | MAP3K1 | 1.19237053 |
| 41 | PKN2 | 1.17963875 |
| 42 | EEF2K | 1.16022215 |
| 43 | MST4 | 1.13987812 |
| 44 | NME2 | 1.13470543 |
| 45 | SIK3 | 1.13260221 |
| 46 | CSF1R | 1.12948964 |
| 47 | PIM1 | 1.09593442 |
| 48 | KDR | 1.08636366 |
| 49 | TESK2 | 1.07879544 |
| 50 | EPHB1 | 1.07224736 |
| 51 | LYN | 1.07224681 |
| 52 | PIK3CG | 1.06694117 |
| 53 | MARK3 | 1.05434825 |
| 54 | PRKCQ | 0.96114928 |
| 55 | MAP3K2 | 0.94169070 |
| 56 | STK4 | 0.93886569 |
| 57 | MAP3K12 | 0.93550180 |
| 58 | MATK | 0.91865894 |
| 59 | TNK2 | 0.88992085 |
| 60 | TRPM7 | 0.88828971 |
| 61 | MAP3K6 | 0.88281650 |
| 62 | MAP3K10 | 0.87990809 |
| 63 | RPS6KA4 | 0.86196482 |
| 64 | JAK2 | 0.84629196 |
| 65 | MARK2 | 0.82224911 |
| 66 | TTN | 0.80408148 |
| 67 | PRKCH | 0.75341565 |
| 68 | RIPK1 | 0.72175760 |
| 69 | TAOK3 | 0.70220947 |
| 70 | PTK2B | 0.68879470 |
| 71 | IRAK3 | 0.68239405 |
| 72 | STK24 | 0.68018881 |
| 73 | TGFBR1 | 0.66085426 |
| 74 | PTK6 | 0.64707867 |
| 75 | MAP3K5 | 0.64040191 |
| 76 | RAF1 | 0.62944011 |
| 77 | TAOK2 | 0.61635054 |
| 78 | PDPK1 | 0.61576922 |
| 79 | IRAK1 | 0.61407936 |
| 80 | CDK19 | 0.60950791 |
| 81 | ERN1 | 0.60203583 |
| 82 | SIK2 | 0.59357557 |
| 83 | HIPK2 | 0.57853116 |
| 84 | CHUK | 0.57327073 |
| 85 | DYRK1B | 0.55481478 |
| 86 | SGK3 | 0.54899100 |
| 87 | MAP2K6 | 0.54072614 |
| 88 | EPHA3 | 0.53989778 |
| 89 | NUAK1 | 0.50626901 |
| 90 | STK11 | 0.50176110 |
| 91 | CDK9 | 0.48904234 |
| 92 | GRK7 | 0.48858316 |
| 93 | MAP3K7 | 0.48458716 |
| 94 | RET | 0.47428720 |
| 95 | PDK1 | 0.46853979 |
| 96 | RIPK4 | 0.44527960 |
| 97 | CAMKK1 | 0.44506952 |
| 98 | STK38 | 0.44368711 |
| 99 | TRIB3 | 0.42315074 |
| 100 | MAP2K4 | 0.41809429 |
| 101 | KSR1 | 0.40378046 |
| 102 | RPS6KA6 | 0.40326210 |
| 103 | PRKD2 | 0.39873794 |
| 104 | ACVR1B | 0.39515702 |
| 105 | MAPK11 | 0.38458347 |
| 106 | CDC42BPA | 0.38173623 |
| 107 | SGK2 | 0.37318473 |
| 108 | IGF1R | 0.37020943 |
| 109 | WNK1 | 0.36897378 |
| 110 | FYN | 0.36537349 |
| 111 | MYLK | 0.36483358 |
| 112 | CDK4 | 0.36222637 |
| 113 | MAPK4 | 0.34955935 |
| 114 | CAMKK2 | 0.34899396 |
| 115 | PDGFRB | 0.33833877 |
| 116 | BRSK2 | 0.33547348 |
| 117 | PRKG2 | 0.33542759 |
| 118 | RPS6KL1 | 0.32927302 |
| 119 | RPS6KC1 | 0.32927302 |
| 120 | MAPKAPK2 | 0.31806527 |
| 121 | ADRBK2 | 0.29588440 |
| 122 | PRKD1 | 0.29566177 |
| 123 | MELK | 0.29364876 |
| 124 | PRKCD | 0.29033903 |
| 125 | RPS6KB2 | 0.28884364 |
| 126 | DAPK2 | 0.27528890 |
| 127 | MAP3K3 | 0.27391636 |
| 128 | MAPK12 | 0.27282874 |
| 129 | SMG1 | 0.26536155 |
| 130 | IRAK2 | 0.26455935 |
| 131 | MAPK7 | 0.26407305 |
| 132 | CDK6 | 0.26026128 |
| 133 | MAP2K2 | 0.25727035 |
| 134 | DMPK | 0.25216686 |
| 135 | ABL1 | 0.24566398 |
| 136 | PASK | 0.24419119 |
| 137 | ALK | 0.23481484 |
| 138 | MAPK3 | 0.23078759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.82290746 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.91959042 |
| 3 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.32310513 |
| 4 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.93377390 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.87782968 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.81357368 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.60325290 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.58327457 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.57843664 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.45468613 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.27362946 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.17694002 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.15571275 |
| 14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.06751333 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.84458729 |
| 16 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.74111760 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.73095776 |
| 18 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.72396213 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.68941590 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.60240787 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59970159 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.59153774 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.57532172 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.49791779 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.46883052 |
| 26 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42853138 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.35869586 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34388045 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.33892168 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.31907427 |
| 31 | Hepatitis B_Homo sapiens_hsa05161 | 1.24898717 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.23895961 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.23648473 |
| 34 | Platelet activation_Homo sapiens_hsa04611 | 1.22919572 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.22181752 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19306944 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.17944574 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.16123369 |
| 39 | Ribosome_Homo sapiens_hsa03010 | 1.15124858 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.15044786 |
| 41 | Malaria_Homo sapiens_hsa05144 | 1.14664984 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.09154476 |
| 43 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08390982 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 0.98934685 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.98420725 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.97285883 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93371043 |
| 48 | Salmonella infection_Homo sapiens_hsa05132 | 0.93307154 |
| 49 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89229223 |
| 50 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.85361776 |
| 51 | Hepatitis C_Homo sapiens_hsa05160 | 0.84230240 |
| 52 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83698198 |
| 53 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82512013 |
| 54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.82311007 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81237549 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.80201189 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.77658525 |
| 58 | Asthma_Homo sapiens_hsa05310 | 0.76999679 |
| 59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76944523 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76506298 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74791891 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74662871 |
| 63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.73954892 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72428632 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.72324265 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69749553 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68477629 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.68305676 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66999252 |
| 70 | Endometrial cancer_Homo sapiens_hsa05213 | 0.65589264 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63077497 |
| 72 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62762654 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61989632 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61149853 |
| 75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.58071587 |
| 76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55922719 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55804703 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54984590 |
| 79 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54435625 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54359895 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54161165 |
| 82 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.49039764 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48732892 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48473984 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47987749 |
| 86 | DNA replication_Homo sapiens_hsa03030 | 0.47072738 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46899548 |
| 88 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44900755 |
| 89 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44725326 |
| 90 | Lysosome_Homo sapiens_hsa04142 | 0.43301417 |
| 91 | Base excision repair_Homo sapiens_hsa03410 | 0.42961835 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42753918 |
| 93 | Mismatch repair_Homo sapiens_hsa03430 | 0.41772110 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41513055 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41248053 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.39950054 |
| 97 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.39625063 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.38949583 |
| 99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38284162 |
| 100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37588623 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35175482 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.34471754 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34147898 |
| 104 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32955399 |
| 105 | ABC transporters_Homo sapiens_hsa02010 | 0.31804921 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28101297 |
| 107 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.26926498 |
| 108 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.25846418 |
| 109 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25251222 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24147302 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.22056247 |
| 112 | Thyroid cancer_Homo sapiens_hsa05216 | 0.21441013 |
| 113 | Phagosome_Homo sapiens_hsa04145 | 0.21327915 |
| 114 | RNA degradation_Homo sapiens_hsa03018 | 0.21318049 |
| 115 | Spliceosome_Homo sapiens_hsa03040 | 0.20017019 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.19661017 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18752300 |
| 118 | Focal adhesion_Homo sapiens_hsa04510 | 0.18223819 |
| 119 | Pathways in cancer_Homo sapiens_hsa05200 | 0.17081623 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.17001755 |

